Here, we describe the epidemiology of RSV, the RSV virion structure, key neutralizing epitopes on the pre- and post-fusion forms of the fusion protein and implications for vaccine development.
Kashmir's leading scientist and gastroenterologist, Prof M Sultran Khuroo writes about the evolution of the Human ...
Research on the respiratory syncytial virus (RSV) polymerase has identified ... of the polymerase's location and function within the virion is essential for grasping how these viruses replicate ...
Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri 63130, United States Center for Biomolecular Condensates, Washington University in St. Louis, St. Louis, ...
COVID-19 and flu activity is increasing in most parts of the country and RSV activity remains very high, especially in young children. Respiratory illness activity in Florida is very high ...
The report also showed emergency department visits for RSV — a common virus that typically causes mild, cold-like symptoms — are at "very high" levels in the state. ER visits for COVID-19 are ...
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased risk for Guillain-Barré Syndrome (GBS) within 42 days of vaccination ...
Pregnant women across Australia will be offered a free vaccine to protect their babies against respiratory syncytial virus (RSV) from next month. The government's $174.5 million investment will ...
Data from the Centers for Disease Control and Prevention showed an increase in three respiratory viruses—COVID-19, flu and RSV—and the gastrointestinal disease norovirus. Emergency department ...
Respiratory syncytial virus causes cold-like symptoms for many people but, for some, it can cause severe illness. Those most vulnerable include the very young. It’s a situation Deanne Tingey is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback